• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 609-623 of 973 results

2411 Exhibit: EX2411 Kombiglyze® XR Prescribing Information rev Feb 2017

Document IPR2023-00724, No. 2411 Exhibit - EX2411 Kombiglyze® XR Prescribing Information rev Feb 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2475 Exhibit: EX2475 Mounjaro Prescribing Information rev July 2023

Document IPR2023-00724, No. 2475 Exhibit - EX2475 Mounjaro Prescribing Information rev July 2023 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2522 Exhibit: EX2522 Novo Nordisk, Ozempic semaglutide injection 05 mg, 1 mg, o...

Document IPR2023-00724, No. 2522 Exhibit - EX2522 Novo Nordisk, Ozempic semaglutide injection 05 mg, 1 mg, or 2 mg WAC Price, httpswwwnovopricingcomozempichtml, last updated Oct 2023 (P.T.A...

cite Cite Document
Analyze

2512 Exhibit: EX2512 Novo Nordisk, Financial report for the period 1 January 2022...

Document IPR2023-00724, No. 2512 Exhibit - EX2512 Novo Nordisk, Financial report for the period 1 January 2022 to 30 September 2022 Nov 2, 2022 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2051 Exhibit: EX2051 Declaration of Anne Flint, Ph D REDACTED

Document IPR2023-00724, No. 2051-2 Exhibit - EX2051 Declaration of Anne Flint, Ph D REDACTED (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2087 Exhibit: EX2087 ADA Standards of Medical Care, Cardiovascular Disease and...

Document IPR2023-00724, No. 2087 Exhibit - EX2087 ADA Standards of Medical Care, Cardiovascular Disease and Risk Management Standards of Medical Care in Diabetes, Diabetes Care 45Suppl 1S1...

cite Cite Document
Analyze

2459 Exhibit: EX2459 Xultophy 10036 Prescribing Information rev Nov 2016

Document IPR2023-00724, No. 2459 Exhibit - EX2459 Xultophy 10036 Prescribing Information rev Nov 2016 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

1120 Exhibit: Exhibit 1120 Saxenda Orange Book

Document IPR2023-00724, No. 1120 Exhibit - Exhibit 1120 Saxenda Orange Book (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1302 Exhibit: Exhibit 1302 Speigel Decl

Document IPR2023-00724, No. 1302 Exhibit - Exhibit 1302 Speigel Decl (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1103 Exhibit: Exhibit 1103 Saxenda label

Document IPR2023-00724, No. 1103 Exhibit - Exhibit 1103 Saxenda label (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1124 Exhibit: Exhibit 1124 GRADE

Document IPR2023-00724, No. 1124 Exhibit - Exhibit 1124 GRADE (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1128 Exhibit: Exhibit 1128 Proposed order

Document IPR2023-00724, No. 1128 Exhibit - Exhibit 1128 Proposed order (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1118 Exhibit: Exhibit 1118

Document IPR2023-00724, No. 1118 Exhibit - Exhibit 1118 (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

2435 Exhibit: EX2435 US Food Drug Administration, DrugsFDA, Farxiga®

Document IPR2023-00724, No. 2435 Exhibit - EX2435 US Food Drug Administration, DrugsFDA, Farxiga® (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2402 Exhibit: EX2402 US Food Drug Administration, DrugsFDA, Janumet® XR

Document IPR2023-00724, No. 2402 Exhibit - EX2402 US Food Drug Administration, DrugsFDA, Janumet® XR (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 41 42 43 44 45 ... >>